Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Atherothrombosis associated with high rates of cardiovascular events within 1 year

Atherothrombosis associated with high rates of cardiovascular events within 1 year

March 21, 2007

Patients with arterial disease have relatively high rates of experiencing a cardiovascular event (such as heart attack, stroke or cardiovascular death) within one year, and these increase with the number of arterial locations afflicted, according to a large, international study in the March 21 issue of JAMA.

Atherothrombosis (arterial disease, such as coronary artery disease [CAD], cerebrovascular disease [CVD], and peripheral arterial disease [PAD; narrowing of the arteries that supply the legs and feet]) is associated with the main causes of death on a worldwide scale, according to background information in the article. "Recent U.S. data have confirmed that, despite a decrease in age-standardized national death rates, the absolute number of deaths from these conditions continues to increase, and prevalence is sharply increasing in other parts of the world. Thus, atherothrombotic diseases are, and are projected still to be, the leading cause of death worldwide by 2020." Few studies have documented the current cardiovascular (CV) event rates in outpatients with atherothrombosis.




Ph. Gabriel Steg, M.D., of the HÃ'pital Bichat-Claude Bernard, Paris, and colleagues examined the characteristics and CV event rates of patients for whom 1-year follow-up data were available from the Reduction of Atherothrombosis for Continued Health (REACH) Registry, an international group of 68,236 patients with either established atherosclerotic arterial disease (such as CAD, PAD, CVD; n = 55,814) or at least three risk factors for atherothrombosis (n = 12,422). The participants were enrolled from 5,587 physician practices in 44 countries in 2003-2004.

As of July 2006, 1-year outcomes were available for 95 percent (n = 64,977) of participants. The researchers found that in the overall stable population with established arterial disease, approximately 1 in 7 patients had a cardiovascular event (CV death, heart attack, and stroke) or was hospitalized for a CV event or revascularization procedure within a year of enrollment. Patients with established arterial disease experienced 2 to 3 times higher event rates than patients with multiple risk factors only.

The overall combined CV death, heart attack, or stroke rate at 1 year was 4.24 percent, ranging from 2.15 percent of patients with multiple risk factors only to 6.47 percent of patients enrolled with CVD and 4.69 percent for those with established atherosclerotic arterial disease.

Among patients with established disease, CV death, heart attack, or stroke rates were 4.52 percent for patients with CAD and 5.35 percent for patients with PAD. The incidences of CV death, heart attack, or stroke or of hospitalization for atherothrombotic event(s) were 15.20 percent for CAD, 14.53 percent for CVD, and 21.14 percent for PAD patients with established disease. These event rates increased directly with the number of symptomatic arterial disease locations, from 5.31 percent for patients with risk factors only, to 12.58 percent for patients with one, 21.14 percent for patients with two and 26.27 percent for patients with three symptomatic arterial disease locations.

"The high event rates observed in this large, stable, contemporary outpatient cohort of patients with established atherosclerotic arterial disease or with multiple atherothrombotic risk factors indicate that continued efforts are needed to improve secondary prevention and clinical outcomes. Initiatives to improve adherence to evidence-based guidelines and care are an important tool in this respect. In addition, the strong association of asymptomatic and symptomatic multiple locations of atherothrombosis with event rates suggests that atherothrombosis should be addressed as a global arterial disease in patients," the authors conclude.

JAMA and Archives Journals



Related Atherothrombosis Current Events and Atherothrombosis News Articles
Surprising rate of recurring heart attacks, strokes globally
Despite many medicines and other treatments for patients with vascular disease, a large international study shows these patients have a surprisingly high rate of recurring events such as strokes, heart attacks and hospitalizations as well as mortality.

New study re-evaluates cardiovascular risks of anti-inflammatory drugs
High doses of some traditional non-steroidal anti-inflammatory drugs (NSAIDS) are associated with similar cardiovascular risks as the new generation of anti-inflammatory drugs known as COX 2 inhibitors (like Vioxx ®), finds a study in this week's BMJ.

Atherothrombosis patients world-wide often have undertreated, undercontrolled risk factors
A large international study demonstrates that patients world-wide with atherothrombosis (coronary artery disease, cerebrovascular disease, peripheral arterial disease) often have cardiovascular risk factors such as obesity and hypertension that are undertreated and undercontrolled.

New anti-thrombotic therapy effective, safer for patients
A Canadian-led study involving researchers from 41 countries has demonstrated in the world's largest study of acute coronary syndromes (ACS) that a new anti-thrombotic therapy is safer and as effective as the traditional therapy used in preventing heart attacks, death and ischemia in people with serious heart conditions.

World Heart Day: Commission launches new research projects to combat cardiovascular disease
September 28 marked World Heart Day. The purpose was to raise awareness on risks and to promote opportunities for preventing heart disease. In the last four years, the European Commission has funded 24 projects in this field, with a contribution of EUR35.5 million. This will be a priority in the future as well, and the EU is about to launch two major projects for a total amount of EUR17 million. An Integrated Project will investigate the genomics of platelets in relation to coronary artery disease. The second project will help better co-ordinate European research in the field of vascular research through a Network of Excellence. These projects will lead to better diagnosis and treatment of p
More Atherothrombosis Current Events and Atherothrombosis News Articles
Antiplatelet Therapy in Atherothrombosis: Supplement Issue: Cerebrovascular Diseases 2006

Antiplatelet Therapy in Atherothrombosis: Supplement Issue: Cerebrovascular Diseases 2006
by S. Uchiyama (Editor), T. Yamaguchi (Editor)



Atherothrombosis And Coronary Artery Disease

Atherothrombosis And Coronary Artery Disease
by Lippincott Williams & Wilkins

Atherothrombosis and Coronary Artery Disease : Atherothrombosis and Coronary Artery Disease Pub Date: November 2004 Product Type: Print Author/s: Valentin Fuster MD, PhD; Eric J Topol MD; Elizabeth G Nabel MD Written by the world's foremost authorities, this volume provides comprehensive coverage of current approaches to the prevention, diagnosis, and management of atherothrombosis and its coronary and noncoronary complications. This edition has been thoroughly updated, sharply focused on clinical information, and trimmed to one manageable volume.Coverage begins with a review of risk factors and prevention, emphasizing lipid abnormalities, hypertension, smoking, diabetes, and obesity. Subsequent sections examine the pathogenesis of atherosclerosis, markers and...

Atherothrombosis and Coronary Artery Disease

Atherothrombosis and Coronary Artery Disease
by Valentin Fuster (Editor), Eric J Topol (Editor), Elizabeth G Nabel (Editor)

Written by the world's foremost authorities, this volume provides comprehensive coverage of current approaches to the prevention, diagnosis, and management of atherothrombosis and its coronary and noncoronary complications. This edition has been thoroughly updated, sharply focused on clinical information, and trimmed to one manageable volume. Coverage begins with a review of risk factors and prevention, emphasizing lipid abnormalities, hypertension, smoking, diabetes, and obesity. Subsequent sections examine the pathogenesis of atherosclerosis, markers and imaging, acute coronary syndromes, chronic stable angina, and noncoronary atherothrombosis. Clinical presentations, medical management, and the latest interventional strategies are included.

Atherothrombosis Management from Early Detection to Long-Term Treatment: Sanofi-Synthelabo and Bristol-Myers Squibb Satellite Symposium to the 10th (Cerebrovascular Diseases)

Atherothrombosis Management from Early Detection to Long-Term Treatment: Sanofi-Synthelabo and Bristol-Myers Squibb Satellite Symposium to the 10th (Cerebrovascular Diseases)
by J. Bogousslavsky (Editor)



  Clinician's Manual on the Evaluation and Management of Atherothrombosis
by J. Bogousslavsky (Author), H. Thurston (Author)



  Atlas of Atherothrombosis
by Russell Hull (Author)



  ATHEROTHROMBOSIS & CORONARY ARTERY DISEA
by FUSTER (Author)



  Clopidogrel: Atherothrombosis (Drugs in Context (US))
by Francesca Bursi (Author), Roy Yawn (Author), Christine Sinsky (Author)



© 2009 BrightSurf.com